Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parhelia Biosciences develops automated devices and consumables that streamline tissue sample preparation and staining for spatial biology applications. Their platforms—Spatial Station™ and Omni-Stainer™—enable hands-free workflows compatible with leading multiplexed imaging technologies such as PhenoCycler/CODEX, Phenoptics/Opal, RNAScope, immunofluorescence/CyCIF/OPAL, H&E staining, imaging mass cytometry (IMC), 10X Visium Spatial Transcriptomics. The company’s solutions improve reproducibility while reducing reagent use and manual labor. They have achieved commercial placements at leading academic institutions and biopharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parhelia Biosciences.